Tripletail Wealth Management, LLC Novo Nordisk A S Transaction History
Tripletail Wealth Management, LLC
- $84.6 Billion
- Q3 2025
A detailed history of Tripletail Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tripletail Wealth Management, LLC holds 196 shares of NVO stock, worth $9,458. This represents 0.01% of its overall portfolio holdings.
Number of Shares
196Holding current value
$9,458% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,697Shares Held
307MCall Options Held
22.6MPut Options Held
30.8M-
Capital International Investors Los Angeles, CA17.7MShares$855 Million0.17% of portfolio
-
Loomis Sayles & CO L P16.2MShares$780 Million1.1% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$675 Million0.21% of portfolio
-
Bank Of America Corp Charlotte, NC13.4MShares$647 Million0.05% of portfolio
-
Morgan Stanley New York, NY12.4MShares$599 Million0.04% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $109B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...